Business Wire

euNetworks Expands Its Long Haul Network to Warsaw and Bratislava, Delivering Three Routes Into Poland to Meet Bandwidth Demand

14.12.2021 14:25:00 EET | Business Wire | Press release

Share

euNetworks Group Limited (“euNetworks”), a Western European bandwidth infrastructure company, today announced that it has expanded its long haul network into Poland, delivering three new routes to Warsaw. These routes deliver around 2,977km of newly lit fibre connecting Warsaw directly with Berlin and Hamburg, with the third route via Brno, supporting traffic to Prague, Bratislava and Vienna. This expansion, which took 9 months to deliver, supports euNetworks’ customers’ demand for better diversity into the region. The system is in service, carrying multiple Terabits of customer traffic on each span that will rapidly grow.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211214005710/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

euNetworks' 3 long routes to Warsaw (Graphic: Business Wire)

The new long haul routes were designed to deliver a unique triverse topology to market. Each route lands in a separate data centre in Warsaw, with scope to further expand as new data centres come into service in the region. The north route is 924km long, extends from Berlin and Hamburg and is unique in the market. Its route diversity also enables customers to bypass Berlin should they need to. The middle route is 845km long, running from euNetworks’ Berlin data centre facility into Warsaw. The south route, at 1,178km, delivers the shortest path to market between Vienna and Warsaw and enables Bratislava in Slovakia as a new point of presence for euNetworks along the way.

These routes connect into the key data centres and data centre hubs in Warsaw. This investment supports euNetworks’ customers’ bandwidth needs in this important market as well as onwards diversity and triversity to the rest of Europe. euNetworks’ long haul network now spans 17 countries, connecting 53 cities. Combined with euNetworks’ extensive metro networks in 17 cities, the long haul network enables any data centre to any data centre connectivity between all these metros on their owned and operated fibre, end-to-end.

The expansion East follows deployment of additional critical infrastructure linking the UK and the Netherlands, with euNetworks’ latest Super Highway along with subsea cable Scylla going live in September 2021.

“Warsaw is an exciting new region for data centre growth and is an important market experiencing strong bandwidth growth,” said Paula Cogan, President, euNetworks. “It’s a growing cloud region in Europe, with its geographic position making it a key connectivity hub for hyperscalers and cloud service providers. We continue to develop our network in support of our customers’ bandwidth requirements across Europe. Our expansion into Poland enables us to continue to offer a seamless and end to end data centre connectivity experience for our customers on our network with the same service delivery and support experience they have come to value.”

euNetworks’ 100g and 400G Wavelengths, 1G and 10G Ethernet, Cloud Connect and Multi Service Port products and solutions are now available in Warsaw, with plans for additional direct connection to further data centres in the region and in Warsaw to support customers’ needs in the future.

euNetworks builds and invests in its city and long haul fibre networks to connect the key data centres and data centre hubs across Europe. The company builds Super Highways on long haul routes that are critical to Europe’s future international bandwidth needs and uses low loss fibre on these routes to deliver a low cost per bit long haul solution for its customers.

About euNetworks

euNetworks is a bandwidth infrastructure company, owning and operating 17 fibre based metropolitan networks connected with a high capacity intercity backbone covering 53 cities in 17 countries across Europe. The company leads the market in data centre connectivity, directly connecting over 465 today. euNetworks is also a leading cloud connectivity provider and offers a targeted portfolio of metropolitan and long haul services including Dark Fibre, Wavelengths, and Ethernet. Wholesale, finance, content, media, mobile, data centre and enterprise customers benefit from euNetworks’ unique inventory of fibre and duct based assets that are tailored to fulfil their high bandwidth needs. For further information visit eunetworks.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

euNetworks contact:
Hannah Britt |
Senior Director, Marketing & IR | euNetworks
hannah.britt@eunetworks.com email
| +44 7717 896 446 mobile

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 12:00:00 EEST | Press release

Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely with healthcare authorities and other stakeholders to support timely access for people with Parkinson’s disease who continue to experience moderate to severe motor fluctuations despite current oral therapies. Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. Despite availab

MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 11:16:00 EEST | Press release

The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav

New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 11:00:00 EEST | Press release

Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich, the findings show that the clinically relevant reductions in low-density lipoprotein cholesterol (LDL-C) achieved within the first year of treatment are estimated to translate into clinically meaningful reductions in 10-year cardiovascular (CV) risk.1 The data further reinforce the clinical value of bempedoic acid, and its fixed-dose combination with ezetimibe, across a diverse range of patient subtypes, regardless of gender and glycaemic profile (diabetes, pre-diabetes, or normoglycemia).2,3 Key findings from the new analyses of the MILOS study include: 10-year CV risk estimate reduction: An analysis of 960 at-risk patients estimated that one year of bempedoic acid-add-on ther

TVS Motor Company Appoints Peyman Kargar as Director and Chief Executive Officer28.8.2026 10:31:00 EEST | Press release

TVS Motor Company, part of TVS VENU and a leading global manufacturer of two and three-wheelers, today announced the appointment of Peyman Kargar as Director and Chief Executive Officer, effective January 27, 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260827012301/en/ Peyman Kargar Peyman will succeed K. N. Radhakrishnan, who will continue in his role until then to ensure a seamless transition. Following the transition, Radhakrishnan will serve as Non-Executive Director up to the date of the ensuing AGM scheduled in July 2027. He has been a tremendous leader and played a pivotal role in the growth of TVS Motor Company. The leadership transition comes as TVS Motor Company builds on strong business performance and continues to consolidate its position in India and expand its global presence. In FY2025-26, the company achieved a record performance, selling 5.9 million vehicles globally and delivering 30% revenue growt

Philips and Imricor Launch Cardiac Interventional MR Lab Solution, Expanding Longstanding Collaboration27.8.2026 22:27:00 EEST | Press release

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Imricor Medical Systems (ASX: IMR), a pioneer and world-leading developer of MR-compatible products for interventional MR procedures, today announced a new Interventional MR (iMR) lab solution for Philips 1.5T MR. The first commercially available configuration* combines Philips’ 1.5T MRI platform and Imricor's portfolio of iMR systems and consumables, enabling an MR-guided workflow for cardiac intervention, without compromising on MR field strength. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260827693715/en/ Meeting the need for greater tissue insight during cardiac intervention Cardiac arrhythmias affect millions of people worldwide, and catheter ablation is an established and increasingly utilized treatment for many complex cardiac arrhythmias. Yet today, these procedures continue to rely primarily on X-ray fluoroscopy, which provides only

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye